Format

Send to

Choose Destination
Reprod Biomed Online. 2011 Dec;23(6):686-91. doi: 10.1016/j.rbmo.2011.09.012. Epub 2011 Sep 29.

PGD and aneuploidy screening for 24 chromosomes by genome-wide SNP analysis: seeing the wood and the trees.

Author information

1
London Bridge Fertility, Gynaecology and Genetics Centre, 1 St. Thomas Street, London SE1 9RY, UK. ahandyside@thebridgecentre.co.uk

Abstract

Bisignano et al. (2011) argue that, for preimplantation genetic diagnosis (PGD) of aneuploidy for all 24 chromosomes, microarray-based comparative genomic hybridization (array CGH) is superior to the use of single-nucleotide polymorphism (SNP) genotyping arrays. Published studies indicate that both technologies accurately detect aneuploidy of whole chromosomes or chromosome segments. However, given the extra theoretical resolution and parent-of-origin information provided by SNP-based approaches, these may be particularly suited to certain applications such as PGD of single-gene defects or translocation chromosome imbalance combined with comprehensive detection of aneuploidy. A consensus on how to validate aneuploidy testing and all other clinically relevant information resulting from genome-wide analysis is needed urgently.

PMID:
22033395
DOI:
10.1016/j.rbmo.2011.09.012
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center